Literature DB >> 3263278

Effect of interleukin 6 (IL-6) on the differentiation and proliferation of murine and human hemopoietic progenitors.

T Suda1, Y Yamaguchi, J Suda, Y Miura, A Okano, Y Akiyama.   

Abstract

We examined the effect of human recombinant (r) interleukin 6 (IL-6) on the differentiation of murine and human hemopoietic progenitors. Human IL-6 supported colony formation by murine bone marrow cells. These colonies consisted of neutrophils and macrophages. Recombinant IL-6 was able to support multilineage colony formation by spleen cells from 5-fluorouracil (5-FU)-treated mice. These colonies consisted of greater than 1 x 10(4) cells. Differential counts revealed large colonies exhibiting different combinations of cell lineages: neutrophils, macrophages, eosinophils, mast cells, and megakaryocytes. However, when blast cell colonies supported by interleukin 3 were replated into secondary dishes containing IL-6, they could differentiate into only neutrophils and macrophages. Single cells transferred from blast cell colonies formed only neutrophil/macrophage colonies. These results indicate that IL-6 had a direct effect on the growth and development of murine granulocyte-macrophage progenitors at a late stage and a significant effect on multipotential hemopoietic precursors that might be indirect through other cells. By contrast, human rIL-6 did not support colony formation by human bone marrow mononuclear cells. IL-6 may not show an independent activity for human hemopoiesis of myeloid lineage. However, the synergistic activity of IL-6 remains to be clarified.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3263278

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  9 in total

1.  Stimulation of thrombopoiesis in mice by human recombinant interleukin 6.

Authors:  R J Hill; M K Warren; J Levin
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

Review 2.  The Jeremiah Metzger lecture. Regulation of hematopoiesis.

Authors:  D G Nathan
Journal:  Trans Am Clin Climatol Assoc       Date:  1990

3.  Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo.

Authors:  J de la Mata; H L Uy; T A Guise; B Story; B F Boyce; G R Mundy; G D Roodman
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

4.  Distinct cytoplasmic regions of the human granulocyte colony-stimulating factor receptor involved in induction of proliferation and maturation.

Authors:  F Dong; C van Buitenen; K Pouwels; L H Hoefsloot; B Löwenberg; I P Touw
Journal:  Mol Cell Biol       Date:  1993-12       Impact factor: 4.272

5.  Suppressive effect of LD78 on the proliferation of human hemopoietic progenitors.

Authors:  H Shiozaki; T Ide; J Nakao; T Imamura; M Nakamura; K Shimada; Y Miura; T Suda
Journal:  Jpn J Cancer Res       Date:  1992-05

6.  Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Inflammatory Biomarkers in Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), and HIV/HCV Coinfection.

Authors:  Jennifer S Hanberg; Matthew S Freiberg; Matthew B Goetz; Maria C Rodriguez-Barradas; Cynthia Gibert; Kris Ann Oursler; Amy C Justice; Janet P Tate
Journal:  Open Forum Infect Dis       Date:  2019-07-26       Impact factor: 3.835

7.  Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus.

Authors:  R G Hawley; A Z Fong; B F Burns; T S Hawley
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

8.  New human oral squamous carcinoma cell line and its tumorigenic subline producing granulocyte colony-stimulating factor.

Authors:  K Matsuo; Y Ishibashi; I Kobayashi; S Ozeki; M Ohishi; T Tange; J Hirata; T Kiyoshima; H Sakai
Journal:  Jpn J Cancer Res       Date:  1994-12

9.  CCR1 and CCR5 mediate cancer-induced myelopoiesis and differentiation of myeloid cells in the tumor.

Authors:  Serena Zilio; Silvio Bicciato; Donald Weed; Paolo Serafini
Journal:  J Immunother Cancer       Date:  2022-01       Impact factor: 12.469

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.